Abstract
Primaquine dose and the risk of haemolysis and Plasmodium vivax recurrence: pooling the available data to reassure the unconvinced
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/s1473-3099(23)00480-2
Copy DOIJournal: The Lancet Infectious Diseases | Publication Date: Sep 22, 2023 |
Primaquine dose and the risk of haemolysis and Plasmodium vivax recurrence: pooling the available data to reassure the unconvinced
Join us for a 30 min session where you can share your feedback and ask us any queries you have